Avita Medical Initiates Trading on US OTCQX

April 2012
Biomedical Market Newsletter;4/1/2012, Vol. 21, p1
The article reports on the trading of the American depositary receipts initiated by the regenerative medical company Avita Medical Ltd. on the OTCQX Markets Group Inc. of the U.S. Trading on the OTCQX marketplace provides helps the U.S. investors of the company with a direct market for participating in the growth of the company. Information on the company's technological innovations and applications is also presented.


Related Articles

  • Avita Medical Announces Free Issuance Period for Conversion of AVMXF Shares to AVMXY ADRs.  // Biomedical Market Newsletter;6/7/2012, Vol. 21, p1 

    The article offers information on the free issuance period announced by Avita Medical Ltd. (AVMXF) through the Bank of New York Mellon Corp. for conversion of AVMXF shares into American Depository Receipts (ADRs). A bundle of 20 ordinary shares is present in each AVMXY ADR which helps in...

  • iSonea Limited Commences Trading on the U.S. OTCQX Intl.  // Biomedical Market Newsletter;1/7/2012, Vol. 21, p1 

    The article reports on the trading of iSonea Ltd. American Depositary Receipts (ADRs) on the OTCQX Markets Group Inc. It is mentioned that the company's ADRs will be traded under the symbol ISOAY to the OTCQX marketplace in the U.S. It furhter states that exclusive OTCQX Advisor of the company...

  • Emerging Market Fund Leads BLDRS Volume.  // Global Finance;Mar2003, Vol. 17 Issue 3, p19 

    Reports on the increasing investor acceptance of the baskets of listed depository receipts in the U.S. Improvement on the visibility of depository receipts; Investment in non-U.S. securities; Assessment of the trading volume.

  • Skin trade: partnership seeks greater understanding of wound healing device.  // Engineer (Online Edition);8/20/2015, p1 

    The article reports on the partnership of Huddersfield University in England and regenerative medicine company Avita Medical Ltd. to explore the mechanism of Regenerative Epithelial Suspension (RES) to better understand its ability to treat cutaneous anomalies including burns.

  • Peter Hambro Mining Starts ADR Program.  // Global Finance;Oct2003, Vol. 17 Issue 9, p14 

    Reports on the launching of a sponsored American Depository Receipt (ADR) Program through the Bank of New York by Peter Hambro Mining in Great Britain. Counterpart of ADR to ordinary shares; Accessibility of shares to international investors; Increase of investment opportunities.

  • Avita Medical Commences Trading on the US OTCQX Intl Exchange.  // Biomedical Market Newsletter;3/14/2012, Vol. 21, p1 

    The article reports that Avita Medical Ltd's. American Depositary Receipts (ADRs) will start trading on the OTCQX International marketplace in the U.S. It is mentioned that company will be traded these ADRs under the symbol AVMXY. It further states that Roth Capital Partners LLC will act as the...

  • Study Demonstrates That Avita Medical's ReCell(r) Spray-On Skin(tm) "Has Potentially Broad Application to the Healing of Acute and Chronic Wounds".  // Biomedical Market Newsletter;5/7/2011, p92 

    The article evaluates ReCell® Spray-On Skin™, from Avita Medical Ltd., a regenerative medicine that been proven with potential broad application in treating acute and chronic wounds.

  • Foreigners Come To U.S., Without Fuss. O'Connor, Colleen Marie // Investment Dealers' Digest;5/16/2005, Vol. 71 Issue 19, p12 

    Reports on the popularity of investments in a special type of American Depository Receipts from foreign issuers in the U.S. since the passage of the Sarbanes-Oxley Act. Trends in trading foreign stocks in the U.S.; Convenience of investing in foreign stocks for Americans; Trading rules and...

  • An Investment Bridge to Europe. Scaglione, Fred // Equities;Fall2006, Vol. 54 Issue 3, p8 

    The article discusses bridging the gap between the European emerging growth companies and the U.S. investors through the American Depository Receipts (ADR). ADR make individual investors in Europe tap into undervalued foreign companies and provide them with capital needed for the company's...


Other Topics